Novozymes A/S (OTCMKTS:NVZMY) Stock Crosses Above 50 Day Moving Average – Time to Sell?

Shares of Novozymes A/S (OTCMKTS:NVZMYGet Free Report) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $63.18 and traded as high as $64.9799. Novozymes A/S shares last traded at $64.63, with a volume of 24,155 shares.

Novozymes A/S Stock Performance

The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.00 and a current ratio of 1.61. The stock has a market cap of $30.41 billion, a PE ratio of 38.24, a PEG ratio of 1.19 and a beta of 1.09. The company’s 50-day moving average price is $63.18 and its two-hundred day moving average price is $63.65.

About Novozymes A/S

(Get Free Report)

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

See Also

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.